ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,189Medicare Part D Prescriptions Filled, Including Refills

Rank: 138 out of 2035

$791K Total Retail Price of All Prescriptions

Rank: 99 out of 2035

533 Patients Receiving at Least One Drug in Part D
53%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 533 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

33% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 4,997 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 1,120 261 S3 1 2
LISINOPRIL 375 213 2 3
SIMVASTATIN 373 191 3 1
OMEPRAZOLE 363 154 4 5
LEVOTHYROXINE SODIUM 286 189 5 4
METFORMIN HCL 278 102 6 9
METOPROLOL TARTRATE 220 104 7 8
MORPHINE SULFATE ER 211 26 S2 8 86
FLUTICASONE PROPIONATE 191 86 9 29
PRAVASTATIN SODIUM 185 125 10 17
GABAPENTIN 184 46 11 14
FUROSEMIDE 177 91 12 7
ZOLPIDEM TARTRATE 175 76 13 21
CITALOPRAM HBR 164 81 14 20
POTASSIUM CHLORIDE 162 80 15 18
ATENOLOL 161 97 16 10
TRAMADOL HCL 135 39 17 19
WARFARIN SODIUM 117 57 18 11
TAMSULOSIN HCL 117 64 18 25
ATORVASTATIN CALCIUM 115 75 20 13
CYCLOBENZAPRINE HCL 114 20 R 21 64
SPIRIVA 106 41 22 44
RANITIDINE HCL 105 32 23 28
PROAIR HFA 105 0 23 31
CIPROFLOXACIN HCL 102 47 25 63
PREDNISONE 99 59 26 36
POLYETHYLENE GLYCOL 3350 97 31 27 48
TRAZODONE HCL 93 31 28 50
VENLAFAXINE HCL ER 91 42 29 130
MELOXICAM 87 40 30 56
SERTRALINE HCL 87 55 30 23
PANTOPRAZOLE SODIUM 85 70 32 42
FLUOXETINE HCL 80 28 33 81
DONEPEZIL HCL 80 79 33 24
NEXIUM 78 28 35 51
IBUPROFEN 76 0 36 43
AMIODARONE HCL 74 52 37 171
AZITHROMYCIN 74 36 37 39
GLIPIZIDE 73 36 39 54
METOPROLOL SUCCINATE 71 32 40 16
OXYCONTIN 68 28 S2 41 152
CLOTRIMAZOLE-BETAMETHASONE 66 0 42 123
AMLODIPINE BESYLATE 66 39 42 6
ALLOPURINOL 64 40 44 34
SPIRONOLACTONE 63 35 45 65
CLOPIDOGREL 62 34 46 30
FENTANYL 59 23 S2 47 53
ADVAIR DISKUS 58 23 48 38
CARVEDILOL 58 44 48 22
COMBIVENT 55 34 50 154
LOSARTAN POTASSIUM 53 31 51 15
CELEBREX 51 31 52 104
NAPROXEN 50 0 53 92
PLAVIX 50 28 53 49
ROPINIROLE HCL 50 35 53 113
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 4, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.